Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) shares have had a really impressive month, gaining 26% after a shaky period beforehand. Looking back a bit further, it’s encouraging to see the stock is up 59% in the last year.
After such a large jump in price, you could be forgiven for thinking Sunshine Guojian Pharmaceutical (Shanghai) is a stock to steer clear of with a price-to-sales ratios (or “P/S”) of 14.8x, considering almost half the companies in China’s Biotechs industry have P/S ratios below 7.5x. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s so lofty.
Check out our latest analysis for Sunshine Guojian Pharmaceutical (Shanghai)
How Has Sunshine Guojian Pharmaceutical (Shanghai) Performed Recently?
With revenue growth that’s superior to most other companies of late, Sunshine Guojian…
